April 30, 2026- Abbott announced it will present six abstracts highlighting strong disease detection and practice-changing evidence during Digestive Disease Week (DDW) 2026, May 2-5, 2026, in Chicago. The data reflect the continued growth of Abbott’s cancer diagnostics portfolio and its focus on addressing critical gaps in cancer detection for patients and clinicians. DDW is the premier meeting for professionals working in gastroenterology, hepatology, GI endoscopy, and gastrointestinal surgery. DDW will make abstracts available on its website on May 2, 2026.
Six additional topics were also accepted for the World Endoscopy Organization Colorectal Cancer Screening Committee meeting on May 1, including data on CRC mortality reduction, follow-up colonoscopy adherence, and comparative performance of multitarget stool DNA testing.